3 Firms Face Off For Lead Counsel Spot In Blood Drug Suit

By Aaron West · March 8, 2023, 4:05 PM EST

It's a battle of law firm resumes as three firms vie for the lead counsel spot to represent investors in a securities class action against an Israeli biotech firm that is...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE BIOLINERX LTD. SECURITIES LITIGATION

Case Number

2:23-cv-00041

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

January 05, 2023